drugset
drugset / Trial / NCT03132194

Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

NCT03132194 ↗

Phase 1 Completed 1125 enrolled Sun Pharmaceutical Industries, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the therapeutic effect of DPSG and Placebo gel in the treatment of acne vulgaris.

Timeline

Start
2016-08-08
Primary completion
2017-01-16
Completion
2017-01-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dapsone Small molecule 7.5 % Topical

Indications

acne